NCT02009722 Intrathecal Opioids for Pain Control After Cesarean Delivery: Determining the Optimal Dose Status COMPLETED Phase PHASE4
NCT01991977 18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy Status COMPLETED Phase PHASE2
NCT01988974 Feasibility Testing of the Alert for Atrial Fibrillation Program Status COMPLETED Phase NA
NCT01981876 Study of Esophageal Squamous Dysplasia Prevalence at Tenwek Hospital Status COMPLETED Phase N/A
NCT01980368 Tai Chi Easy in Treating Cancer Survivors With Peripheral Sensory Neuropathy Status WITHDRAWN Phase NA
NCT01978535 Iron Sucrose in Adolescents With Iron Deficiency and Postural Orthostatic Tachycardia Syndrome (POTS) Status TERMINATED Phase PHASE1/PHASE2
NCT01978509 The Affect of Low-Volume Bowel Preparation for Hospitalized Patients Colonoscopies Status TERMINATED Phase NA
NCT01975402 Evaluation of the BodyGuardian End-to-end Remote Monitoring Platform in an Outpatient Heart Failure Population Status COMPLETED Phase N/A
NCT01973829 The Checklist for Early Recognition and Treatment of Acute Illness (CERTAIN) Status COMPLETED Phase NA
NCT01970176 Study to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Systolic Cardiomyopathy (Aim2) Status COMPLETED Phase PHASE1/PHASE2
NCT01969240 Shared Decision Making in the Emergency Department: Chest Pain Choice Trial Status COMPLETED Phase NA
NCT01968772 Effect of Transdermal Magnesium Chloride on Quality of Life in Patients With Fibromyalgia Status COMPLETED Phase NA
NCT01957956 Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Status COMPLETED Phase EARLY_PHASE1
NCT01956929 Metformin's Effect on Glucagon-induced Glucose Production and Protein Metabolism. Status COMPLETED Phase PHASE1
NCT01955434 SMAC Mimetic LCL161 Alone or With Cyclophosphamide in Treating Patients With Relapsed or Refractory Multiple Myeloma Status COMPLETED Phase PHASE2
NCT01953640 Gene Expression in Patients With Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy Status COMPLETED Phase N/A